Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer.

Ch'ang HJ, Huang CL, Wang HP, Shiah HS, Chang MC, Jan CM, Chen JS, Tien YW, Hwang TL, Lin JT, Cheng AL, Whang-Peng J, Chen LT.

Cancer Chemother Pharmacol. 2009 Nov;64(6):1173-9. doi: 10.1007/s00280-009-0980-2. Epub 2009 Mar 25.

PMID:
19319535
2.

Phase II study of leucovorin, 5-fluorouracil and gemcitabine for locally advanced and metastatic pancreatic cancer (FOLFUGEM 2).

André T, Noirclerc M, Hammel P, Meckenstock R, Landi B, Cattan S, Selle F, Codoul JF, Guerrier-Parmentier B, Mokhtar R, Louvet C; GERCOR.

Gastroenterol Clin Biol. 2004 Aug-Sep;28(8-9):645-50. Review.

PMID:
15646530
3.

The role of oxaliplatin in the management of upper gastrointestinal tract malignancies.

Scheithauer W, Van Cutsem E.

Colorectal Dis. 2003 Nov;5 Suppl 3:36-44. Review.

PMID:
23573559
4.

Emerging drugs in pancreatic cancer.

Ducreux M, Boige V, Malka D.

Expert Opin Emerg Drugs. 2004 May;9(1):73-89. Review.

PMID:
15155137
5.

What options are available for refractory pancreatic cancer?

Choi M, Kim R, Saif MW.

JOP. 2012 Mar 10;13(2):163-5. Review.

6.

Locally advanced pancreatic cancer.

Oikonomopoulos GM, Huber KE, Syrigos KN, Saif MW.

JOP. 2013 Mar 10;14(2):126-8. doi: 10.6092/1590-8577/1469. Review.

7.

A comprehensive update on the use of chemotherapy for metastatic pancreatic adenocarcinoma.

Kozuch P, Petryk M, Bruckner HW.

Hematol Oncol Clin North Am. 2002 Feb;16(1):123-38. Review.

PMID:
12063823
8.

[Second line chemotherapy for pancreatic cancer].

Park JY.

Korean J Gastroenterol. 2011 Apr;57(4):207-12. doi: 10.4166/2011.57.4.207. Review. Korean.

9.

Gemox: a widely useful therapy against solid tumors-review and personal experience.

Meriggi F, Zaniboni A.

J Chemother. 2010 Oct;22(5):298-303. Review.

PMID:
21123151
10.

Pancreatic cancer in 2010: new insights for early intervention and detection.

Costello E, Neoptolemos JP.

Nat Rev Gastroenterol Hepatol. 2011 Feb;8(2):71-3. doi: 10.1038/nrgastro.2010.214. Review.

PMID:
21293504

Supplemental Content

Support Center